Enabling point of care screening for sepsis using rapid single cell analysis
Ended Project Grant Awarded Last action
- Award ID
- R44HL123878
- Recipient
-
Cytovale Inc. UEI TG7HM4HD8594
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,484,141
Award facts
- Assistance listing
- 93.839 Blood Diseases and Resources Research
- Completion date
- Place of performance
- San Francisco, CA 94134, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $734,141 | |
| Original award | $750,000 |
Quick answers
Who received award R44HL123878?
R44HL123878 was awarded to Cytovale Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2014.
How much is award R44HL123878 worth?
$1,484,141 has been obligated on R44HL123878.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award